Skip to content
Bored Studies
RecruitingPhase 2/Phase 3

A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)

EyeBiotech Ltd. · NCT07440225

View Study & Apply (opens in a new tab)

Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.

Key facts

Compensation
Not posted. Ask the study team before screening.
Who can join
Ages 50+ · All sexes
Healthy volunteers
Not accepted (a condition is required)
Study type
Interventional · Phase 2, Phase 3
Target enrollment
960
US sites recruiting
67
Study start
March 27, 2026
Record last updated
October 2, 2026

Status re-checked against ClinicalTrials.gov within the last 12 hours.

What the study is about

Researchers are looking for new ways to treat neovascular age-related macular degeneration (NVAMD).

Available standard (usual) treatments for NVAMD, such as aflibercept, may not work for every person. Researchers want to learn if a trial medicine called tiespectus (also called MK-8748 or EYE201) can treat NVAMD.

The goal of this trial is to learn if tiespectus works as well as aflibercept to treat NVAMD.

Being studied: Tiespectus; Aflibercept

Conditions: Macular Degeneration; Age-Related Macular Degeneration; Choroidal Neovascularization; Wet Macular Degeneration

Eligibility criteria

Copied from the official record. The study team makes the final decision at screening.

Show full criteria

The main inclusion criteria include but are not limited to the following:

  • Has treatment naive choroidal neovascularization (CNV) secondary to age-related macular degeneration (AMD) including subfoveal, juxtafoveal and extrafoveal lesions or retinal angiomatous proliferations (RAP) and polypoidal choroidal vascularization (PCV) lesions in at least one eye (study eye)
  • The diagnosis of neovascular age-related macular degeneration (NVAMD) must have been made within 21 days prior to starting study treatment

The main exclusion criteria include but are not limited to the following

  • Has uncontrolled blood pressure at screening
  • History of any prior macular laser photocoagulation in the study eye
  • History of uveitis in either eye
  • History of cataract surgery, minimally invasive glaucoma surgery, or Yttrium-Aluminium Garnet (Yag) laser capsulotomy in the study eye within 90 days before entering the study
  • Has uncontrolled glaucoma in the study eye
  • Active retinal disease other than the condition under investigation in the study eye
  • Has previously received anti- vascular endothelial growth factor (VEGF) therapy or other intravitreal (IVT) therapy in the study eye

Recruiting US locations

  • Research Network Arizona / Retina Macula Institute of Arizona

    Scottsdale, AZ 85255

    Site contact: Study Coordinator · 602-613-5473

  • Retina Center of Arkansas

    Fayetteville, AR 72703

    Site contact: Study Coordinator · 479-234-4499

  • Retina Partners of Northwest Arkansas, PLLC

    Springdale, AR 72764

    Site contact: Study Coordinator · 479-408-4470

  • Global Research Management, Inc.

    Glendale, CA 91204

    Site contact: 818-246-2560

  • Retinal Consultants Medical Group (Site 024)

    Modesto, CA 95356

    Site contact: Study Coordinator · 209-521-6173

  • Azul Vision / California Eye Specialists Medical Group, Inc.

    Pasadena, CA 91107

    Site contact: Study Coordinator · 661-609-2475

  • Retina Consultants of Southern California (Site 043)

    Redlands, CA 92374

    Site contact: Study Coordinator · 951-788-0222

  • Retinal Consultants Medical Group (Site 020)

    Sacramento, CA 95825

    Site contact: Study Coordinator · 916-974-9279

  • Retinal Consultants Medical Group (Site 022)

    Sacramento, CA 95841

    Site contact: Study Coordinator · 916-339-3650

  • Florida Eye Clinic (Site 130)

    Altamonte Springs, FL 32701

    Site contact: Study Coordinator · 407-775-7495

  • Retina Group of Florida (Site 070)

    Fort Lauderdale, FL 33308

    Site contact: Study Coordinator · 954-776-6880

  • Vitreo Retinal Associates

    Gainesville, FL 32607

    Site contact: 352-300-8412

  • Florida Retina Institute

    Jacksonville, FL 32216

    Site contact: Study Coordinator · 206-338-0248

  • Florida Retina Consultants

    Lakeland, FL 33805

    Site contact: Study Coordinator · 863-682-7474

  • South Florida Retina Institute

    Miami, FL 33180

    Site contact: Study Coordinator · 786-590-1777

  • Retina Care Specialists

    Palm Beach Gardens, FL 33410

    Site contact: Study Coordinator · 561-408-0853

  • Fort Lauderdale Eye Institute (Site 042)

    Plantation, FL 33324

    Site contact: Study Coordinator · 954-635-2861

  • Retina Vitreous Associates of Florida (Site 049)

    St. Petersburg, FL 33711

    Site contact: Study Coordinator · 727-323-0077

  • Southern Vitreoretinal Associates

    Tallahassee, FL 32308

    Site contact: Study Coordinator · 850-942-6700

  • Retina Associates of Florida, LLC

    Tampa, FL 33609

    Site contact: Study Coordinator · 616-438-9395

  • Retina Vitreous Associates of Florida

    Tampa, FL 33617

    Site contact: Study Coordinator · 813-987-2000

  • Wildwood Clinical Research / Florida Retina Institute

    Wildwood, FL 34785

    Site contact: Study Coordinator · 407-473-5596

  • Illinois Retina Associates

    Oak Park, IL 60304

    Site contact: Study Coordinator · 872-222-0139

  • Springfield Clinic

    Springfield, IL 62703

    Site contact: Study Coordinator · 217-528-7541

  • Associated Vitreoretinal and Uveitis Consultants

    Carmel, IN 46032

    Site contact: Study Coordinator · 317-571-1501

  • Midwest Eye Institute

    Carmel, IN 46032

    Site contact: Study Coordinator · 317-805-2152

  • Cumberland Valley Retina Consultants (Site 007)

    Hagerstown, MD 21740

    Site contact: Study Coordinator · 301-665-1712

  • Foundation for Vision Research (Site 073)

    Grand Rapids, MI 49546

    Site contact: Study Coordinator · 616-438-9395

  • Retina Consultants of Minnesota

    Saint Louis Park, MN 55416

    Site contact: Study Coordinator · 952-259-4285

  • Retina Specialists of Mississippi

    Hattiesburg, MS 39402

    Site contact: Study Coordinator · 601-255-0736

  • Mississippi Retina Associates (Site 084)

    Madison, MS 39110

    Site contact: Study Coordinator · 601-981-4091

  • Mid Atlantic Retina

    Cherry Hill, NJ 08034

    Site contact: Study Coordinator · 215-928-3092

  • Vision Research Center Eye Associates of New Mexico

    Albuquerque, NM 87109

    Site contact: Study Coordinator · 505-393-7483

  • ong Island Vitreoretinal Consultants / Vitreoretinal Consultants of NY (Site 105)

    Hauppauge, NY 11788

    Site contact: Study Coordinator · 516-466-0390

  • Retina Vitreous Surgeons of CNY, PC (Site 033)

    Liverpool, NY 13088

    Site contact: Study Coordinator · 315-445-8166

  • Piedmont Retina Specialists - Greensboro

    Greensboro, NC 27401

    Site contact: Study Coordinator · 336-369-7160

  • North Carolina Retina Associates

    Greenville, NC 27834

    Site contact: Study Coordinator · 919-782-8038

  • Piedmont Retina Specialists - Winston-Salem

    Winston-Salem, NC 27103

    Site contact: Study Coordinator · 336-397-9216

  • Cincinnati Eye Institute (Site 133)

    Cincinnati, OH 45242

    Site contact: Study Coordinator · 513-569-3462

  • Retina Vitreous Center

    Edmond, OK 73013

    Site contact: Study Coordinator · 405-607-6699

  • Tulsa Retina Consultants

    Tulsa, OK 74114

    Site contact: Study Coordinator · 918-395-0872

  • Retina Northwest, PC

    Portland, OR 97221

    Site contact: Study Coordinator · 971-865-2781

  • EyeHealth Northwest

    Portland, OR 97225

    Site contact: Study Coordinator · 503-296-6484

  • Mid Atlantic Retina (Site 050)

    Bethlehem, PA 18017

    Site contact: Study Coordinator · 516-466-0390

  • Palmetto Retina Center

    Aiken, SC 29803

    Site contact: Study Coordinator · 803-867-7058

  • Charleston Neuroscience Institute - Bluffton (Site 124)

    Bluffton, SC 29910

    Site contact: Study Coordinator · 843-278-9938

  • Charleston Neuroscience Institute (Site 104)

    Charleston, SC 29414

    Site contact: Study Coordinator · 843-972-3857

  • Charleston Neuroscience Institute (CNI) d/b/a Retina Consultants of South Carolina

    Mt. Pleasant, SC 29464

    Site contact: Study Coordinator · 843-763-4466

  • Charles Retina Institute

    Germantown, TN 38138

    Site contact: Study Coordinator · 901-683-0399

  • Retina Research Institute of Texas (Site 010)

    Abilene, TX 79606

    Site contact: Study Coordinator · 325-690-4414

  • Southwest Retina Specialists

    Amarillo, TX 79106

    Site contact: Study Coordinator · 806-350-1113

  • Texas Retina Associates

    Arlington, TX 76012

    Site contact: Study Coordinator · 682-433-5453

  • Austin Research Center for Retina

    Austin, TX 78705

    Site contact: Study Coordinator · 512-454-5851

  • Austin Retina Associates (Site 012)

    Austin, TX 78705

    Site contact: Study Coordinator · 512-451-0103

  • Retina & Vitreous of Texas

    Bellaire, TX 77401

    Site contact: Study Coordinator · 281-249-9076

  • Texas Retina Associates

    Dallas, TX 75231

    Site contact: Study Coordinator · 800-695-6941

  • Texas Retina (Site 037)

    Plano, TX 75075

    Site contact: Study Coordinator · 469-560-0177

  • Retina Center of Texas

    Southlake, TX 76092

    Site contact: Study Coordinator · 817-865-6800

  • Retina Consultants of Texas (Site 014)

    The Woodlands, TX 77384

    Site contact: Study Coordinator · 713-524-3434

  • Tyler Retina Research Institute

    Tyler, TX 75703

    Site contact: Study Coordinator · 903-597-4644

+ 7 more on the official record.

Study contacts (from the official record)

  • Toll Free Number · 1-888-577-8839 · Trialsites@msd.com
A Clinical Trial of EYE201/MK-8748 in People With Macular… (NCT07440225) | Bored Studies